---
figid: PMC9540797__VCO-20-602-g001
pmcid: PMC9540797
image_filename: VCO-20-602-g001.jpg
figure_link: /pmc/articles/PMC9540797/figure/vco12813-fig-0005/
number: FIGURE 5
figure_title: ''
caption: Monitoring effects on WBCs. Changes to WBC numbers (A), numbers and percentages
  of neutrophils (B and C), lymphocytes (D and E), monocytes (F and G) and eosinophils
  (H and I) were measured over time. Only dogs with a potential toxic effect are identified,
  as per Figure
article_title: Developing a translational murine‐to‐canine pathway for an IL‐2/agonist
  anti‐CD40 antibody cancer immunotherapy.
citation: Stephen Francis Proksch, et al. Vet Comp Oncol. 2022 Sep;20(3):602-612.
year: '2022'

doi: 10.1111/vco.12813
journal_title: Veterinary and Comparative Oncology
journal_nlm_ta: Vet Comp Oncol
publisher_name: Blackwell Publishing Ltd

keywords:
- anti‐CD40 antibody
- dogs
- immunotherapy
- interleukin‐2
- soft tissue sarcoma

---
